SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-20-002252
Filing Date
2020-01-08
Accepted
2020-01-08 16:01:21
Documents
2
Period of Report
2020-01-06

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm201560d2_3.html 3  
1 OWNERSHIP DOCUMENT tm201560d2_3.xml 3 1631
2 EXHIBIT 24 tm201560d2_ex24.htm EX-24 3755
  Complete submission text file 0001104659-20-002252.txt   6899
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Issuer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 15 REID LANE MILLSTONE TWP NJ 08535
Business Address
Grachev Igor D (Reporting) CIK: 0001798815 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36598 | Film No.: 20515777